These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 34628633)

  • 1. Liquid Chromatography-Mass Spectrometry for Clinical Metabolomics: An Overview.
    Furlani IL; da Cruz Nunes E; Canuto GAB; Macedo AN; Oliveira RV
    Adv Exp Med Biol; 2021; 1336():179-213. PubMed ID: 34628633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
    Khamis MM; Adamko DJ; El-Aneed A
    Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Untargeted detection of the carbonyl metabolome by chemical derivatization and liquid chromatography-tandem mass spectrometry in precursor ion scan mode: Elucidation of COVID-19 severity biomarkers.
    Gomez-Gomez A; Rodríguez-Morató J; Haro N; Marín-Corral J; Masclans JR; Pozo OJ
    Anal Chim Acta; 2022 Mar; 1196():339405. PubMed ID: 35151400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases.
    Cui L; Lu H; Lee YH
    Mass Spectrom Rev; 2018 Nov; 37(6):772-792. PubMed ID: 29486047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for large-scale targeted metabolomics quantification by liquid chromatography-mass spectrometry.
    Zhou J; Yin Y
    Analyst; 2016 Nov; 141(23):6362-6373. PubMed ID: 27722450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing coverage in LC-MS-based untargeted metabolomics by a new sample preparation procedure using mixed-mode solid-phase extraction and two derivatizations.
    Wu Q; Xu Y; Ji H; Wang Y; Zhang Z; Lu H
    Anal Bioanal Chem; 2019 Sep; 411(23):6189-6202. PubMed ID: 31414155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: A review.
    Roux A; Lison D; Junot C; Heilier JF
    Clin Biochem; 2011 Jan; 44(1):119-35. PubMed ID: 20800591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untargeted LC/MS-based metabolic phenotyping (metabonomics/metabolomics): The state of the art.
    Gika H; Virgiliou C; Theodoridis G; Plumb RS; Wilson ID
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jun; 1117():136-147. PubMed ID: 31009899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of simultaneous targeted metabolite quantification and untargeted metabolomics strategy using dual-column liquid chromatography coupled with tandem mass spectrometry.
    Gao Y; Chen Y; Yue X; He J; Zhang R; Xu J; Zhou Z; Wang Z; Zhang R; Abliz Z
    Anal Chim Acta; 2018 Dec; 1037():369-379. PubMed ID: 30292313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current state-of-the-art of nontargeted metabolomics based on liquid chromatography-mass spectrometry with special emphasis in clinical applications.
    Yin P; Xu G
    J Chromatogr A; 2014 Dec; 1374():1-13. PubMed ID: 25444251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An untargeted metabolomics-driven approach based on LC-TOF/MS and LC-MS/MS for the screening of xenobiotics and metabolites of Zhi-Zi-Da-Huang decoction in rat plasma.
    Wu H; Li X; Yan X; An L; Luo K; Shao M; Jiang Y; Xie R; Feng F
    J Pharm Biomed Anal; 2015 Nov; 115():315-22. PubMed ID: 26275719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome.
    Xu W; Chen D; Wang N; Zhang T; Zhou R; Huan T; Lu Y; Su X; Xie Q; Li L; Li L
    Anal Chem; 2015 Jan; 87(2):829-36. PubMed ID: 25486321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC-MS Untargeted Analysis.
    Want EJ
    Methods Mol Biol; 2018; 1738():99-116. PubMed ID: 29654585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailored liquid chromatography-mass spectrometry analysis improves the coverage of the intracellular metabolome of HepaRG cells.
    Cuykx M; Negreira N; Beirnaert C; Van den Eede N; Rodrigues R; Vanhaecke T; Laukens K; Covaci A
    J Chromatogr A; 2017 Mar; 1487():168-178. PubMed ID: 28153450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of chemical isotope labeling liquid chromatography mass spectrometry for silkworm hemolymph metabolomics.
    Shen W; Han W; Li Y; Meng Z; Cai L; Li L
    Anal Chim Acta; 2016 Oct; 942():1-11. PubMed ID: 27720112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
    Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
    J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming Sample Matrix Effect in Quantitative Blood Metabolomics Using Chemical Isotope Labeling Liquid Chromatography Mass Spectrometry.
    Chen D; Han W; Su X; Li L; Li L
    Anal Chem; 2017 Sep; 89(17):9424-9431. PubMed ID: 28787119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary metabolic phenotyping of mucopolysaccharidosis type I combining untargeted and targeted strategies with data modeling.
    Tebani A; Schmitz-Afonso I; Abily-Donval L; Héron B; Piraud M; Ausseil J; Brassier A; De Lonlay P; Zerimech F; Vaz FM; Gonzalez BJ; Marret S; Afonso C; Bekri S
    Clin Chim Acta; 2017 Dec; 475():7-14. PubMed ID: 28982054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlap in serum metabolic profiles between non-related diseases: Implications for LC-MS metabolomics biomarker discovery.
    Lindahl A; Forshed J; Nordström A
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1472-7. PubMed ID: 27581198
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.